{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022615","form_type":"8-K","ticker":"CNTN","cik":"0001861657","company_name":"Canton Strategic Holdings, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.423525+00:00","generated_at":"2026-05-17T18:21:29.110134+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tharimmune appoints Nancy Davis to board of directors","bullets":["Nancy Davis, founder of Race to Erase MS and Cure Addiction Now, joins Tharimmune board effective August 4, 2025.","Davis brings patient advocacy expertise and has raised over $56M for MS research through her foundation.","Her appointment aligns with Tharimmune's focus on TH104 for opioid countermeasures and broader pipeline.","Davis will serve until the 2026 annual meeting, with compensation consistent with other non-employee directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022615","json":"https://secwatch.observer/filing/0001641172-25-022615.json","markdown":"https://secwatch.observer/filing/0001641172-25-022615.md","text":"https://secwatch.observer/filing/0001641172-25-022615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861657/000164117225022615/0001641172-25-022615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861657/000164117225022615/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:21:29.110134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}